These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37228093)

  • 1. Public health evaluation of PFAS exposures and breastfeeding: a systematic literature review.
    Hoadley L; Watters M; Rogers R; Siegmann Werner L; Markiewicz KV; Forrester T; McLanahan ED
    Toxicol Sci; 2023 Jul; 194(2):121-137. PubMed ID: 37228093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly- and perfluoroalkyl substances (PFAS) exposure through infant feeding in early life.
    van Beijsterveldt IALP; van Zelst BD; de Fluiter KS; van den Berg SAA; van der Steen M; Hokken-Koelega ACS
    Environ Int; 2022 Jun; 164():107274. PubMed ID: 35524998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: A global issue.
    LaKind JS; Naiman J; Verner MA; Lévêque L; Fenton S
    Environ Res; 2023 Feb; 219():115042. PubMed ID: 36529330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in perfluoroalkyl substances (PFAS) concentrations in human milk over the course of lactation: A study in Ronneby mother-child cohort.
    Blomberg AJ; Haug LS; Lindh C; Sabaredzovic A; Pineda D; Jakobsson K; Nielsen C
    Environ Res; 2023 Feb; 219():115096. PubMed ID: 36529327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.
    Rokoff LB; Wallenborn JT; Harris MH; Rifas-Shiman SL; Criswell R; Romano ME; Young JG; Calafat AM; Oken E; Sagiv SK; Fleisch AF
    Sci Total Environ; 2023 Sep; 891():164724. PubMed ID: 37290653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the dynamic early life exposure to PFOA and PFOS of the HELIX children: Emerging profiles via prenatal exposure, breastfeeding, and diet.
    Ratier A; Casas M; Grazuleviciene R; Slama R; Småstuen Haug L; Thomsen C; Vafeiadi M; Wright J; Zeman FA; Vrijheid M; Brochot C
    Environ Int; 2024 Apr; 186():108621. PubMed ID: 38593693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Transfer of Perfluoroalkyl Substances (PFAS) from Maternal Serum to Breast Milk in Women Highly Exposed from Contaminated Drinking Water: A Study in the Ronneby Mother-Child Cohort.
    Blomberg AJ; Norén E; Haug LS; Lindh C; Sabaredzovic A; Pineda D; Jakobsson K; Nielsen C
    Environ Health Perspect; 2023 Jan; 131(1):17005. PubMed ID: 36688826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal poly- and perfluoroalkyl substances (PFAS) levels in Dutch infants.
    van Beijsterveldt IALP; van Zelst BD; van den Berg SAA; de Fluiter KS; van der Steen M; Hokken-Koelega ACS
    Environ Int; 2022 Feb; 160():107068. PubMed ID: 34968992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrences of legacy and emerging per- and polyfluoroalkyl substances in human milk in China: Results of the third National Human Milk Survey (2017-2020).
    Han F; Wang Y; Li J; Lyu B; Liu J; Zhang J; Zhao Y; Wu Y
    J Hazard Mater; 2023 Feb; 443(Pt A):130163. PubMed ID: 36272370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Per- and polyfluoroalkyl substances (PFAS) and thyroid hormone measurements in dried blood spots and neonatal characteristics: a pilot study.
    Rosen Vollmar AK; Lin EZ; Nason SL; Santiago K; Johnson CH; Ma X; Godri Pollitt KJ; Deziel NC
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):737-747. PubMed ID: 37730931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma per- and polyfluoroalkyl substance mixtures during pregnancy and duration of breastfeeding in the New Hampshire birth cohort study.
    Romano ME; Gallagher LG; Price G; Crawford KA; Criswell R; Baker E; Botelho JC; Calafat AM; Karagas MR
    Int J Hyg Environ Health; 2024 May; 258():114359. PubMed ID: 38521049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review.
    VanNoy BN; Lam J; Zota AR
    Curr Environ Health Rep; 2018 Jun; 5(2):213-224. PubMed ID: 29737463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects.
    Blake BE; Fenton SE
    Toxicology; 2020 Oct; 443():152565. PubMed ID: 32861749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse birth outcomes related to concentrations of per- and polyfluoroalkyl substances (PFAS) in maternal blood collected from pregnant women in 1960-1966.
    Zheng T; Kelsey K; Zhu C; Pennell KD; Yao Q; Manz KE; Zheng YF; Braun JM; Liu Y; Papandonatos G; Liu Q; Shi K; Brochman S; Buka SL
    Environ Res; 2024 Jan; 241():117010. PubMed ID: 37696323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review.
    Bach CC; Bech BH; Brix N; Nohr EA; Bonde JP; Henriksen TB
    Crit Rev Toxicol; 2015 Jan; 45(1):53-67. PubMed ID: 25372700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal and postnatal exposure to emerging and legacy per-/polyfluoroalkyl substances: Levels and transfer in maternal serum, cord serum, and breast milk.
    Zheng P; Liu Y; An Q; Yang X; Yin S; Ma LQ; Liu W
    Sci Total Environ; 2022 Mar; 812():152446. PubMed ID: 34952085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Prenatal and Early Postnatal Exposure to Perfluoroalkyl Substances and IQ Score in 7-Year-Old Children From the Odense Child Cohort.
    Beck IH; Bilenberg N; Möller S; Nielsen F; Grandjean P; Højsager FD; Halldorsson TI; Nielsen C; Jensen TK
    Am J Epidemiol; 2023 Sep; 192(9):1522-1535. PubMed ID: 37119029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.